Synairgen (SNG) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Oct 2020 11:05 AM
RNS
Second Price Monitoring Extn
12 Oct 2020 11:00 AM
RNS
Price Monitoring Extension
06 Oct 2020 08:55 AM
RNS
Holding(s) in Company
02 Oct 2020 07:00 AM
RNS
Appointment of Joint Broker
01 Oct 2020 02:06 PM
RNS
Second Price Monitoring Extn
01 Oct 2020 02:00 PM
RNS
Price Monitoring Extension
01 Oct 2020 11:00 AM
RNS
Price Monitoring Extension
29 Sep 2020 07:00 AM
RNS
Synairgen and Clinigen sign Managed Access Program
29 Sep 2020 07:00 AM
RNS
Interim results for six months ended 30 June 2020
09 Sep 2020 07:00 AM
RNS
Synairgen IP Update
08 Sep 2020 07:00 AM
RNS
Positive interim analysis of SNG001 in COPD
07 Sep 2020 03:53 PM
RNS
Holding(s) in Company
03 Sep 2020 05:58 PM
RNS
Holding(s) in Company
01 Sep 2020 04:41 PM
RNS
Second Price Monitoring Extn
01 Sep 2020 04:36 PM
RNS
Price Monitoring Extension
24 Aug 2020 04:41 PM
RNS
Second Price Monitoring Extn
24 Aug 2020 04:36 PM
RNS
Price Monitoring Extension
21 Aug 2020 05:28 PM
RNS
Holding(s) in Company
13 Aug 2020 04:41 PM
RNS
Second Price Monitoring Extn
13 Aug 2020 04:35 PM
RNS
Price Monitoring Extension
13 Aug 2020 07:57 AM
RNS
Holding(s) in Company
10 Aug 2020 09:50 AM
RNS
Holding(s) in Company
07 Aug 2020 08:22 AM
RNS
Holding(s) in Company
05 Aug 2020 05:51 PM
RNS
Holding(s) in Company
31 Jul 2020 08:37 AM
RNS
Holding(s) in Company
29 Jul 2020 04:43 PM
RNS
Holding(s) in Company
28 Jul 2020 03:13 PM
RNS
Holding(s) in Company
28 Jul 2020 09:01 AM
RNS
Holding(s) in Company
27 Jul 2020 09:06 AM
RNS
Second Price Monitoring Extn
27 Jul 2020 09:00 AM
RNS
Price Monitoring Extension
23 Jul 2020 04:40 PM
RNS
Second Price Monitoring Extn
23 Jul 2020 04:36 PM
RNS
Price Monitoring Extension
22 Jul 2020 02:05 PM
RNS
Holding(s) in Company
21 Jul 2020 04:15 PM
RNS
Holding(s) in Company
21 Jul 2020 07:00 AM
RNS
Holding(s) in Company
21 Jul 2020 07:00 AM
RNS
Clarification Regarding COVID-19 Trial
20 Jul 2020 04:40 PM
RNS
Second Price Monitoring Extn
20 Jul 2020 04:35 PM
RNS
Price Monitoring Extension
20 Jul 2020 11:05 AM
RNS
Second Price Monitoring Extn
20 Jul 2020 11:00 AM
RNS
Price Monitoring Extension
20 Jul 2020 09:05 AM
RNS
Second Price Monitoring Extn
20 Jul 2020 09:00 AM
RNS
Price Monitoring Extension
20 Jul 2020 07:01 AM
Synairgen announces positive results from trial...
20 Jul 2020 07:00 AM
RNS
Positive results from trial in COVID-19 patients
15 Jul 2020 08:00 AM
RNS
Holding(s) in Company
03 Jul 2020 12:43 PM
RNS
Holding(s) in Company
03 Jul 2020 12:38 PM
RNS
Holding(s) in Company
29 Jun 2020 03:18 PM
RNS
Result of AGM
22 Jun 2020 04:41 PM
RNS
Second Price Monitoring Extn
22 Jun 2020 04:36 PM
RNS
Price Monitoring Extension

Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.

Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.

Synairgen share price launched at 155p in 2004.

UK 100

Latest directors dealings